Kos, Abbott end promotion deal

KOSP and ABT will discontinue on Jan. 1, 2002 their 1999 U.S. co-promotion deal for ABT's hypertension products Mavik trandolapril, an angiotensin converting enzyme inhibitor, and Tarka trandolapril/e...